Semaglutide vs Tirzepatide vs Retatrutide
Semaglutide (GLP-1)
The most established GLP-1 therapy, designed for reliable appetite control and steady, sustainable fat loss.
Tirzepatide (GLP-1 + GIP)
A dual-pathway metabolic therapy offering enhanced weight reduction and improved insulin sensitivity.
Retatrutide (Triple Agonist)
A next-generation triple-agonist therapy targeting multiple metabolic pathways for advanced body composition outcomes.